22 hours Down -35.74% in 4 Weeks, Here’s Why PDS Biotechnology (PDSB) Looks Ripe for a TurnaroundZacks
The heavy selling pressure might have exhausted for PDS Biotechnology (PDSB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
X